Endometriosis Trial, Recruiting (NCT04166825)

Endometriosis Trial, Recruiting NCT04166825 Sponsor: Jagiellonian University Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT04166825 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with infertility, as defined by World Health Organization (WHO) 2010 guidelines

Who may not be able to join:

Your ovaries are affected by a condition relevant to this trial (confirm with trial site)
You have used birth control pills in the last 3 months
You have taken a hormone medication called dienogest within 3 months before starting fertility treatment
You have a history of blood clots (such as deep vein thrombosis or pulmonary embolism)
You have severely high blood pressure
You have diabetes
You have known risk factors for blood clots, including obesity, a recent major surgery with a long period of limited movement, or a serious injury
You have a deficiency in certain natural proteins that help control blood clotting (antithrombin, protein C, or protein S)
You have a condition called antiphospholipid syndrome, which affects the immune system and can cause blood clots
You have a known cancer diagnosis
You have any long-term inflammatory condition, such as rheumatoid arthritis
You have advanced kidney disease (confirm with trial site)
Your blood clotting level (called INR) is above 1.2 on the day of your blood test (confirm with trial site)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04166825

Sponsor: Jagiellonian University

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

More information: https://clinicaltrials.gov/study/NCT04166825

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with infertility, as defined by World Health Organization (WHO) 2010 guidelines

Who may not be able to join:

Your ovaries are affected by a condition relevant to this trial (confirm with trial site)
You have used birth control pills in the last 3 months
You have taken a hormone medication called dienogest within 3 months before starting fertility treatment
You have a history of blood clots (such as deep vein thrombosis or pulmonary embolism)
You have severely high blood pressure
You have diabetes
You have known risk factors for blood clots, including obesity, a recent major surgery with a long period of limited movement, or a serious injury
You have a deficiency in certain natural proteins that help control blood clotting (antithrombin, protein C, or protein S)
You have a condition called antiphospholipid syndrome, which affects the immune system and can cause blood clots
You have a known cancer diagnosis
You have any long-term inflammatory condition, such as rheumatoid arthritis
You have advanced kidney disease (confirm with trial site)
Your blood clotting level (called INR) is above 1.2 on the day of your blood test (confirm with trial site)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jagiellonian University

Registry

ClinicalTrials.gov

Start date

18 November 2019

Est. completion

1 January 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Fibrin clot properties before and after the ovarian hyperstimulation.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov